she received a flu vaccine on the same day as this Covid Booser Vaccine; she received a flu vaccine on the same day as this Covid Booser Vaccine; she's been itching so much its turned into a rash./Itching all over, is allergic to that/Every time, it itches; she's been itching so much its turned into a rash.; is allergic to that; it has gotten worse; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 85-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Oct2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 85 years, in left arm for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 25Oct2022 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 2, SINGLE), administration date: 06Jul2021, when the patient was 83-year-old, for COVID-19 immunization, reaction(s): "every time, it itches"; Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "every time, it itches". The following information was reported: HYPERSENSITIVITY (non-serious) with onset Oct2022, outcome "not recovered", described as "is allergic to that"; CONDITION AGGRAVATED (non-serious) with onset Oct2022, outcome "unknown", described as "it has gotten worse"; RASH (non-serious) with onset Oct2022, outcome "unknown", described as "she's been itching so much its turned into a rash."; PRURITUS (non-serious) with onset Oct2022, outcome "not recovered", described as "she's been itching so much its turned into a rash./Itching all over, is allergic to that/Every time, it itches"; OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 25Oct2022, outcome "unknown" and all described as "she received a flu vaccine on the same day as this Covid Booser Vaccine". Therapeutic measures were taken as a result of pruritus.  Additional information: Patient received the bivalent gray cap formulation of the Pfizer BioNTech Covid 19 vaccine and she had been itching so much its turned into a rash. States that she was itching all over and was allergic to that. She received a COVID Vaccine Booster and was itching all over. States that she told them it itches, and it has gotten worse. Patient stated that this started in Oct2022, and it has gotten worse. States she was using an unspecified itch cream. Patient had no dates or Lot Numbers available for any of her previous doses of the COVID Vaccines. Mentions that every time, it itches. Patient mentions having her second dose of the COVID Vaccine, she thinks, on 06Jul2021. Patient denies any concomitant medications. Patient then states that she had some unspecified pill the doctor gave her and then said it is bad for the patient brain. No further information provided related to this unspecified pill. Patient cannot recall how many doses of the COVID Vaccines she had prior to the booster that she received on 25Oct2022. Prior Vaccinations (within 4 weeks): If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine Patient states that she received a flu vaccine on the same day as this COVID Booster Vaccine, 25Oct2022; NDC, Lot Number, Expiry Date was Unknown by the patient.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201322830 same reporter/patient, diffrent drug dose/event;US-PFIZER INC-202201322724 same reporter/patient, diffrent drug dose/event;